Toxicological evaluation of preservative-containing and preservative-free topical prostaglandin analogues on a three-dimensional-reconstituted corneal epithelium system

British Journal of Ophthalmology

Volumn 95, Issue 6, 2011, Pages 869-875

  Liang, Hong ^a,b,c,d,e   Pauly, Aude ^b,c,d,e   Riancho, Luisa ^b,c,d,e   Baudouin, Christophe ^a,b,c,d,e,f   Brignole Baudouin, Françoise ^b,c,d,e,f,g  

^a CENTRE HOSPITALIER NATIONAL D OPHTALMOLOGIE DES QUINZE VINGTS   (France)

^b INSERM   (France)

^c SORBONNE UNIVERSITÉ   (France)

^d INSTITUT DE LA VISION   (France)

^e CNRS   (France)

^f LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^g Department of Toxicology   (France)

Author keywords

[No Author keywords available]

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; BENZALKONIUM CHLORIDE; BIMATOPROST; DNA NUCLEOTIDYLEXOTRANSFERASE; EYE DROPS; INTERCELLULAR ADHESION MOLECULE 1; KI 67 ANTIGEN; LATANOPROST; OCCLUDIN; PROSTAGLANDIN; PROTEIN ZO1; TAFLUPROST; TRAVOPROST;

APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL VIABILITY; CONCENTRATION RESPONSE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CORNEA EPITHELIUM; DRUG CYTOTOXICITY; DRUG TOLERABILITY; FLUORESCENCE MICROSCOPY; FROZEN SECTION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; NICK END LABELING; PRIORITY JOURNAL; TOXICITY TESTING;

ANTIHYPERTENSIVE AGENTS; APOPTOSIS; BENZALKONIUM COMPOUNDS; CELL PROLIFERATION; CELL SURVIVAL; CONJUNCTIVA; EPITHELIUM, CORNEAL; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; MODELS, BIOLOGICAL; OPHTHALMIC SOLUTIONS; PRESERVATIVES, PHARMACEUTICAL; PROSTAGLANDINS F; TIGHT JUNCTIONS; TOXICITY TESTS;

EID: 79956363646     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjo.2010.189449     Document Type: Article

References (23)

1. Nakajima T, Matsugi T, Goto W, et al. New fluoroprostaglandin F(2alpha) derivatives with prostanoid FP-receptor agonistic activity as potent ocularhypotensive agents. Biol Pharm Bull 2003;26:1691-5. (Pubitemid 39663527)
2. Brasnu E, Brignole-Baudouin F, Riancho L, et al. In vitro effects of preservative-free tafluprost and preserved latanoprost, travoprost, bimatoprost in a conjunctival epithelial cell line. Curr Eye Res 2008;14:204-16.
3. Liang H, Baudouin C, Pauly A, et al. Conjunctival and corneal reactions in rabbits following short- and repeated exposure to preservative-free tafluprost, commercially available latanoprost and 0.02% benzalkonium chloride. Br J Ophthalmol 2008;92:1275-82.
4. Doucet O, Lanvin M, Thillou C, et al. Reconstituted human corneal epithelium: a new alternative to the Draize eye test for the assessment of the eye irritation potential of chemicals and cosmetic products. Toxicol In Vitro 2006;20:499-512.
5. Pauly A, Meloni M, Brignole-Baudouin F, et al. Multiple endpoint analysis of the 3D-reconstituted corneal epithelium (SkinEthicTM) after treatment with benzalkonium chloride: modified MTT procedure and new markers for the early detection of toxic damage. Invest Ophthalmol Vis Sci 2009;50:1644-52.
6. Manciocco A, Chiarotti F, Vitale A, et al. The application of Russell and Burch 3R principle in rodent models of neurodegenerative disease: the case of Parkinson's disease. Neurosci Biobehav Rev 2009;33:18-32.
7. Cotovio J, Grandidier MH, Lelièvre D, et al. In vitro assessment of eye irritancy using the Reconstructed Human Corneal Epithelial SkinEthic HCE model: application to 435 substances from consumer products industry. Toxicol In Vitro 2010;24:523-37.
8. Baudouin C, Labbé A, Liang H, et al. Preservatives in eyedrops: the good, the bad and the ugly. Prog Retin Eye Res 2010;29:312-34.
9. Nguyen DH, Beuerman RW, De Wever B, et al. Three-dimensional construct of the human corneal epithelium for in vitro toxicology. In: Salem H, Katz SA, eds. Alternative Toxicological Methods. Boca Raton, FL: CRC Press, 2003:147-59.
10. Doucet O, Lanvin M, Zastrow L. A new in vitro human epithelial model for assessing the eye irritating potential of formulated cosmetic products. Vitro Mol Toxicol 1998;11:315-51.
11. Meloni M, Pauly A, Servi BD, et al. Occludin gene expression as an early in vitro sign for mild eye irritation assessment. Toxicol In Vitro 2010;24:276-85.
12. Baudouin C, Garcher C, Haouat N, et al. Expression of inflammatory membrane markers by conjunctival cells in chronically treated patients with glaucoma. Ophthalmology 1994;101:454-60. (Pubitemid 24100569)
13. Baudouin C, Hamard P, Liang H, et al. Conjunctival epithelial cell expression of interleukins and inflammatory markers in glaucoma patients treated over the long term. Ophthalmology 2004;111:2186-92. (Pubitemid 39575587)
14. De Saint Jean M, Brignole F, Bringuier AF, et al. Effects of benzalkonium chloride on growth and survival of Chang conjunctival cells. Invest Ophthalmol Vis Sci 1999;40:619-30. (Pubitemid 29109440)
15. Pisella PJ, Debbasch C, Hamard P, et al. Conjunctival proinflammatory and proapoptotic effects of latanoprost and preserved and unpreserved timolol: an ex vivo and in vitro study. Invest Ophthalmol Vis Sci 2004;45:1360-8. (Pubitemid 38859312)
16. Asbell PA, Potapova N. Effects of topical antiglaucoma medications on the ocular surface. Ocul Surf 2005;3:27-40. (Pubitemid 40347578)
17. Leung EW, Medeiros FA, Weinreb RN. Prevalence of ocular surface disease in glaucoma patients. J Glaucoma 2008;17:350-5.
18. Hong J, Bielory L. Allergy to ophthalmic preservatives. Curr Opin Allergy Clin Immunol 2009;9:447-53.
19. Guenoun JM, Baudouin C, Rat P, et al. In vitro study of inflammatory potential and toxicity profile of latanoprost, travoprost, and bimatoprost in conjunctiva-derived epithelial cells. Invest Ophthalmol Vis Sci 2005;46:2444-50.
20. Khoh-Reiter S, Jessen BA. Evaluation of the cytotoxic effects of ophthalmic solutions containing benzalkonium chloride on corneal epithelium using an organotypic 3-D model. BMC Ophthalmol 2009;9:5.
21. Friedlaender MH, Breshears D, Amoozgar B, et al. The dilution of benzalkonium chloride (BAC) in the tear film. Adv Ther 2006;23:835-41. (Pubitemid 46341041)
22. Champeau EJ, Edelhauser HF. Effect of ophthalmic preservatives on the ocular surface: conjunctival and corneal uptake and distribution of benzalkonium chloride and chlorhexidine digluconate. In: Holly FJ, ed. The Preocular Tear Film. Lubbock, TX: Dry Eye Institute, 1986.
23. Green K, Chapman J. Benzalkonium chloride kinetics in young and adult albino and pigmented rabbit eyes. Cutan Ocul Toxicol 1986;5:133-42. (Pubitemid 16094636)